You are here: Industry Insights > Financing

News List

Drug contamination test maker Rapid Micro secures $60M in financing to expand fiercepharma
May 04, 2018
Rapid Micro Biosystems, maker of microbial detection technology for drug manufacturers, secured $60 million in financing to expand its global reach and develop new products.
Innovent Biologics completed US$150 million Series E round financing biospace
April 27, 2018
Innovent Biologics, Inc., a leading biotech company in China, is pleased to announce the completion of its US$150 million Series E round financing.
Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure biospace
April 27, 2018
Cardiac Dimensions, Inc., a leader in the development of innovative, minimally invasive treatments for patients with heart failure, today announced the company has closed a $39 million Series B financing.
Rallybio Established by Industry Leaders with $37.0 Million in Series A Financing to Develop Transformative Therapies for Patients with Severe and Rare Diseases biospace
April 26, 2018
Rallybio, LLC today announced that it has secured $37.0 million in Series A funding.
X-Biotix Therapeutics, Inc. Secures $7 million in Series A Financing biospace
April 25, 2018
X-Biotix Therapeutics, Inc.announced that the company has secured $7 million in a Series A financing from a group of private investors.
Tetherex Pharmaceuticals, Inc. Completes $50M Series B Financing biospace
April 19, 2018
Tetherex Pharmaceuticals, Inc.today announced that the company has successfully closed on a $50 million private placement of Series B preferred stock.
Predicine Closes Series A Financing Totaling $13.5M biospace
April 17, 2018
Predicine, a Hayward, Calif.-based precision medicine company, today announced it has completed its $13.5M Series A financing from Sangel Capital, Rongsheng Investment, and Highlight Capital.
Abionic Successfully Raises CHF20 Million in Series C Financing biospace
March 29, 2018
Abionic AB, a developer of disruptive nanotechnology based rapid diagnostic solutions, announced today the successful closing of a CHF20 million Series C financing
Singlera Genomics Raises $60 Million in Series A+ Financing biospace
March 28, 2018
Singlera Genomics today announced that it has successfully secured a US$60 million Series A+ financing round led by Green Pine Capital Partners and Prosperico Ventures with participation from new and existing investors,
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing biospace
March 22, 2018
TCR2 Therapeutics Inc.,announced today the completion of an oversubscribed Series B financing of $125 million.

Previous page 1 2 3 4 5 6 7 Next page